353 related articles for article (PubMed ID: 18974095)
41. Association of focal adhesion kinase with tuberous sclerosis complex 2 in the regulation of s6 kinase activation and cell growth.
Gan B; Yoo Y; Guan JL
J Biol Chem; 2006 Dec; 281(49):37321-9. PubMed ID: 17043358
[TBL] [Abstract][Full Text] [Related]
42. ULK1 inhibits the kinase activity of mTORC1 and cell proliferation.
Jung CH; Seo M; Otto NM; Kim DH
Autophagy; 2011 Oct; 7(10):1212-21. PubMed ID: 21795849
[TBL] [Abstract][Full Text] [Related]
43. A germ line mutation in the death domain of DAPK-1 inactivates ERK-induced apoptosis.
Stevens C; Lin Y; Sanchez M; Amin E; Copson E; White H; Durston V; Eccles DM; Hupp T
J Biol Chem; 2007 May; 282(18):13791-803. PubMed ID: 17244621
[TBL] [Abstract][Full Text] [Related]
44. Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide.
Parkhitko AA; Priolo C; Coloff JL; Yun J; Wu JJ; Mizumura K; Xu W; Malinowska IA; Yu J; Kwiatkowski DJ; Locasale JW; Asara JM; Choi AM; Finkel T; Henske EP
Mol Cancer Res; 2014 Jan; 12(1):48-57. PubMed ID: 24296756
[TBL] [Abstract][Full Text] [Related]
45. Distinct roles for mammalian target of rapamycin complexes in the fibroblast response to transforming growth factor-beta.
Rahimi RA; Andrianifahanana M; Wilkes MC; Edens M; Kottom TJ; Blenis J; Leof EB
Cancer Res; 2009 Jan; 69(1):84-93. PubMed ID: 19117990
[TBL] [Abstract][Full Text] [Related]
46. The FoxO-BNIP3 axis exerts a unique regulation of mTORC1 and cell survival under energy stress.
Lin A; Yao J; Zhuang L; Wang D; Han J; Lam EW; Gan B
Oncogene; 2014 Jun; 33(24):3183-94. PubMed ID: 23851496
[TBL] [Abstract][Full Text] [Related]
47. Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy.
Valianou M; Cox AM; Pichette B; Hartley S; Paladhi UR; Astrinidis A
Cell Cycle; 2015; 14(3):399-407. PubMed ID: 25565629
[TBL] [Abstract][Full Text] [Related]
48. Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression.
Linke M; Pham HT; Katholnig K; Schnöller T; Miller A; Demel F; Schütz B; Rosner M; Kovacic B; Sukhbaatar N; Niederreiter B; Blüml S; Kuess P; Sexl V; Müller M; Mikula M; Weckwerth W; Haschemi A; Susani M; Hengstschläger M; Gambello MJ; Weichhart T
Nat Immunol; 2017 Mar; 18(3):293-302. PubMed ID: 28092373
[TBL] [Abstract][Full Text] [Related]
49. Tuberin activates and controls the distribution of Rac1 via association with p62 and ubiquitin through the mTORC1 signaling pathway.
Okura H; Kobayashi T; Koike M; Ohsawa M; Zhang D; Arai H; Uchiyama Y; Hino O
Int J Oncol; 2013 Aug; 43(2):447-56. PubMed ID: 23759924
[TBL] [Abstract][Full Text] [Related]
50. The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling.
Anjum R; Roux PP; Ballif BA; Gygi SP; Blenis J
Curr Biol; 2005 Oct; 15(19):1762-7. PubMed ID: 16213824
[TBL] [Abstract][Full Text] [Related]
51. Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells.
Chen W; Pan Y; Wang S; Liu Y; Chen G; Zhou L; Ni W; Wang A; Lu Y
BMC Cancer; 2017 Jan; 17(1):34. PubMed ID: 28061838
[TBL] [Abstract][Full Text] [Related]
52. TSC2 N-terminal lysine acetylation status affects to its stability modulating mTORC1 signaling and autophagy.
García-Aguilar A; Guillén C; Nellist M; Bartolomé A; Benito M
Biochim Biophys Acta; 2016 Nov; 1863(11):2658-2667. PubMed ID: 27542907
[TBL] [Abstract][Full Text] [Related]
53. Heterozygous inactivation of tsc2 enhances tumorigenesis in p53 mutant zebrafish.
Kim SH; Kowalski ML; Carson RP; Bridges LR; Ess KC
Dis Model Mech; 2013 Jul; 6(4):925-33. PubMed ID: 23580196
[TBL] [Abstract][Full Text] [Related]
54. Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition.
Han EK; Leverson JD; McGonigal T; Shah OJ; Woods KW; Hunter T; Giranda VL; Luo Y
Oncogene; 2007 Aug; 26(38):5655-61. PubMed ID: 17334390
[TBL] [Abstract][Full Text] [Related]
55. Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling.
Chen Y; Wei H; Liu F; Guan JL
J Biol Chem; 2014 Jan; 289(2):1164-73. PubMed ID: 24275666
[TBL] [Abstract][Full Text] [Related]
56. Identification of a dominant negative functional domain on DAPK-1 that degrades DAPK-1 protein and stimulates TNFR-1-mediated apoptosis.
Lin Y; Stevens C; Hupp T
J Biol Chem; 2007 Jun; 282(23):16792-802. PubMed ID: 17324927
[TBL] [Abstract][Full Text] [Related]
57. Statins in lymphangioleiomyomatosis. Simvastatin and atorvastatin induce differential effects on tuberous sclerosis complex 2-null cell growth and signaling.
Atochina-Vasserman EN; Goncharov DA; Volgina AV; Milavec M; James ML; Krymskaya VP
Am J Respir Cell Mol Biol; 2013 Nov; 49(5):704-9. PubMed ID: 23947572
[TBL] [Abstract][Full Text] [Related]
58. Identification of a new form of death-associated protein kinase that promotes cell survival.
Jin Y; Blue EK; Dixon S; Hou L; Wysolmerski RB; Gallagher PJ
J Biol Chem; 2001 Oct; 276(43):39667-78. PubMed ID: 11485996
[TBL] [Abstract][Full Text] [Related]
59. Targeted knockdown of death-associated protein kinase expression induces TRAIL-mediated apoptosis in human endometrial adenocarcinoma cells.
Bai T; Tanaka T; Yukawa K
Int J Oncol; 2010 Jul; 37(1):203-10. PubMed ID: 20514412
[TBL] [Abstract][Full Text] [Related]
60. mTORC1 promotes survival through translational control of Mcl-1.
Mills JR; Hippo Y; Robert F; Chen SM; Malina A; Lin CJ; Trojahn U; Wendel HG; Charest A; Bronson RT; Kogan SC; Nadon R; Housman DE; Lowe SW; Pelletier J
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10853-8. PubMed ID: 18664580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
